Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Intel Trader who wrote (4745)	7/6/1998 10:01:00 AM
From: Steve Fancy	of 6136

RESEARCH ALERT-Morgan cuts Agouron (NASDAQ:AGPH) 98 EPS Reuters, Monday, July 06, 1998 at 09:18 NEW YORK, July 6 (Reuters) - Morgan Stanley Dean Witter said Monday that analyst Doug Lind reduced his 1998 EPS estimate for Agouron Pharmaceuticals Inc. to $0.41 from $0.70. -- says due to up-front license fees for three recently in-licensed compounds. -- 1999 EPS estimate remains unchanged at $1.29. -- Agouron shares closed Friday at 28-11/16. Copyright 1998, Reuters News Service

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next